222 related articles for article (PubMed ID: 34127702)
1. Lysyl oxidase inhibitors attenuate cyclosporin A-induced nephropathy in mouse.
Nguyen LT; Saad S; Shi Y; Wang R; Chou ASY; Gill A; Yao Y; Jarolimek W; Pollock CA
Sci Rep; 2021 Jun; 11(1):12437. PubMed ID: 34127702
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy.
Stangenberg S; Saad S; Schilter HC; Zaky A; Gill A; Pollock CA; Wong MG
Sci Rep; 2018 Jun; 8(1):9423. PubMed ID: 29930330
[TBL] [Abstract][Full Text] [Related]
3. Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis.
Yao Y; Findlay A; Stolp J; Rayner B; Ask K; Jarolimek W
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628342
[TBL] [Abstract][Full Text] [Related]
4. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.
Schilter H; Findlay AD; Perryman L; Yow TT; Moses J; Zahoor A; Turner CI; Deodhar M; Foot JS; Zhou W; Greco A; Joshi A; Rayner B; Townsend S; Buson A; Jarolimek W
J Cell Mol Med; 2019 Mar; 23(3):1759-1770. PubMed ID: 30536539
[TBL] [Abstract][Full Text] [Related]
5. Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice.
Leiva O; Ng SK; Matsuura S; Chitalia V; Lucero H; Findlay A; Turner C; Jarolimek W; Ravid K
Int J Hematol; 2019 Dec; 110(6):699-708. PubMed ID: 31637674
[TBL] [Abstract][Full Text] [Related]
6. Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling.
Hong YA; Lim JH; Kim MY; Kim EN; Koh ES; Shin SJ; Choi BS; Park CW; Chang YS; Chung S
J Transl Med; 2014 Feb; 12():50. PubMed ID: 24559268
[TBL] [Abstract][Full Text] [Related]
7. Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy.
Ye M; Song Y; Pan S; Chu M; Wang ZW; Zhu X
Pharmacol Ther; 2020 Nov; 215():107633. PubMed ID: 32693113
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
[TBL] [Abstract][Full Text] [Related]
9. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis.
Chen W; Yang A; Jia J; Popov YV; Schuppan D; You H
Hepatology; 2020 Aug; 72(2):729-741. PubMed ID: 32176358
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of Lysyl Oxidases Expression in Diabetic Nephropathy and Renal Cell Carcinoma.
Añazco C; Cerro S; Pereira N; Rojas C; Torres Á; Vidal-Beltrán I
Curr Drug Targets; 2021; 22(17):1916-1925. PubMed ID: 34879794
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia.
Xu XH; Jia Y; Zhou X; Xie D; Huang X; Jia L; Zhou Q; Zheng Q; Zhou X; Wang K; Jin LP
Exp Mol Med; 2019 Feb; 51(2):1-12. PubMed ID: 30804321
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation.
Ling H; Li X; Jha S; Wang W; Karetskaya L; Pratt B; Ledbetter S
J Am Soc Nephrol; 2003 Feb; 14(2):377-88. PubMed ID: 12538738
[TBL] [Abstract][Full Text] [Related]
13. Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy.
Shihab FS; Andoh TF; Tanner AM; Bennett WM
Am J Kidney Dis; 1997 Jul; 30(1):71-81. PubMed ID: 9214404
[TBL] [Abstract][Full Text] [Related]
14. Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts.
Mižíková I; Palumbo F; Tábi T; Herold S; Vadász I; Mayer K; Seeger W; Morty RE
Physiol Genomics; 2017 Aug; 49(8):416-429. PubMed ID: 28698228
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 mediated up-regulation of lysyl oxidase in the kidneys of hereditary nephrotic mouse with chronic renal fibrosis.
Goto Y; Uchio-Yamada K; Anan S; Yamamoto Y; Ogura A; Manabe N
Virchows Arch; 2005 Nov; 447(5):859-68. PubMed ID: 16086153
[TBL] [Abstract][Full Text] [Related]
16. Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells.
Yang Z; Xiaohua W; Lei J; Ruoyun T; Mingxia X; Weichun H; Li F; Ping W; Junwei Y
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F336-46. PubMed ID: 20484295
[TBL] [Abstract][Full Text] [Related]
17. 2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth.
Smithen DA; Leung LMH; Challinor M; Lawrence R; Tang H; Niculescu-Duvaz D; Pearce SP; Mcleary R; Lopes F; Aljarah M; Brown M; Johnson L; Thomson G; Marais R; Springer C
J Med Chem; 2020 Mar; 63(5):2308-2324. PubMed ID: 31430136
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of N-glycosylation by glucosamine hydrochloride inhibits TGF-β1-induced LOXL2 secretion.
Kamiya T; Kadowaki M; Atobe T; Kunieda K; Morimoto K; Hara H
J Cell Biochem; 2023 Jun; 124(6):797-807. PubMed ID: 37062903
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of Cavernosal Fibrosis and Erectile Function by Lysyl Oxidase Inhibition in a Rat Model of Cavernous Nerve Injury.
Wan ZH; Li GH; Guo YL; Li WZ; Chen L; Zhang YJ
J Sex Med; 2018 Mar; 15(3):304-313. PubMed ID: 29502979
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis.
Aumiller V; Strobel B; Romeike M; Schuler M; Stierstorfer BE; Kreuz S
Sci Rep; 2017 Mar; 7(1):149. PubMed ID: 28273952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
